Dr. Brian Bostick, M.D.
Cardiology (Cardiovascular Disease Physician)
500 N Keene St Ste 406
Columbia, MO 65201
Who else practices at this address →
Boone County is a federal dental shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Missouri, Columbia School of Medicine (2010)
- Years since graduation
- 16
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 475
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Medical school: University of Missouri, Columbia School of Medicine
- 2010Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
MO license 2012020075 -
Internal Medicine Physician
MO license 2010019745
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Missouri Health Care Columbia, MO
- Bothwell Regional Health Center Sedalia, MO
- Macon County Samaritan Memorial Hospital Macon, MO
- Moberly Regional Medical Center Moberly, MO
- Fitzgibbon Hospital Marshall, MO
Medical groups
- The Curators of the University of Missouri (1,131 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 475
- Services billed
- 1,635
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 385 | 248 |
| Established patient office or other outpatient visit, 40-54 minutes | 129 | 107 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 57 | 39 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 45 | 38 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 41 | 25 |
| Established patient office or other outpatient visit, 20-29 minutes | 39 | 35 |
| New patient office or other outpatient visit, 60-74 minutes | 34 | 34 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 31 | 29 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 22 | 18 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 21 | 21 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 3 payments worth $80.09 in total to this clinician.
| Medtronic, Inc. | $80.09 |
|---|
| Food and Beverage | $80.09 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $33,379 in research payments for these studies, mostly to the institutions running them.
- A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat,MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction
Merck Sharp & Dohme LLC - A Randomised,Double Blind,Placebo Controlled,Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants with Uncontrolled Hypertension on Two or More Medications including Participants with R…
AstraZeneca Pharmaceuticals LP
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.